Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares

DUBLIN, Ireland and KING OF PRUSSIA, Pa. , July 25, 2018 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ:NBRV) today announced that it has commenced an underwritten public offering of $50.0 million of ordinary shares. In addition, Nabriva Therapeutics expects to grant the underwriters an


Leave a Reply

Your email address will not be published.